|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.61 CNY | +2.71% |
|
+9.52% | -6.43% |
| 07-10 | China Includes Hubei Jumpcan Pharmaceutical's Granules for Colds in Children in Essential Drug List | MT |
| 06-09 | Jumpcan Pharma Gets Registration Certificate for Marboxil Tablets | MT |
| Market Cap | 22.68B 3.35B 2.93B 2.7B 2.49B 4.73B 319B 4.81B 32.25B 12.66B 157B 12.56B 12.29B 540B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 11.7B 1.73B 1.51B 1.39B 1.29B 2.44B 165B 2.48B 16.63B 6.53B 81.05B 6.48B 6.34B 279B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
37.54% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.71% | ||
| 1 week | +9.52% | ||
| Current month | +10.91% | ||
| 1 month | -9.22% | ||
| 3 months | -2.07% | ||
| 6 months | -5.64% | ||
| Current year | -6.43% |
| 1 week | 22.8 |  | 24.81 |
| 1 month | 21.13 | | 27.49 |
| Current year | 21.13 | | 29.6 |
| 1 year | 21.13 | | 29.6 |
| 3 years | 21.13 | | 45.18 |
| 5 years | 14.37 | | 45.18 |
| 10 years | 14.37 | | 54.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
Fei Cao
CEO | Chief Executive Officer | 43 | 20/12/2019 |
Hong Cun Yan
DFI | Director of Finance/CFO | 58 | 26/09/2022 |
Zhigang Chang
IRC | Investor Relations Contact | 29 | 22/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Qu Rong Huang
BRD | Director/Board Member | 64 | 10/03/2014 |
Fei Cao
BRD | Director/Board Member | 43 | 10/03/2014 |
Long Xiang Cao
CHM | Chairman | 69 | 10/03/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12-01 | Buy | Director | 30,000 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.71% | +9.52% | -6.14% | -8.78% | 3.26B | |
| +1.90% | +1.82% | -11.27% | -6.90% | 12.85B | |
| +3.59% | +5.01% | -31.29% | -52.81% | 4.79B | |
| +4.15% | +3.48% | -3.60% | -5.91% | 4.4B | |
| +6.19% | +5.44% | +10.39% | -32.89% | 3.82B | |
| +3.72% | -3.85% | +15.82% | -4.31% | 3.68B | |
| +2.13% | +2.71% | -9.27% | +6.52% | 3.1B | |
| +1.03% | +2.29% | -7.29% | -21.36% | 2.41B | |
| +4.33% | +9.31% | -1.05% | +52.08% | 1.8B | |
| +3.44% | +2.62% | -7.46% | -11.97% | 1.68B | |
| Average | +3.32% | +3.86% | -5.12% | -8.63% | 4.18B | |
| Weighted average by Cap. | +3.08% | +3.54% | -7.02% | -11.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 1.72B 254M 222M 205M 189M 360M 24.25B 366M 2.45B 963M 11.95B 955M 934M 41.07B | - |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | CN¥24.61 | +2.71% | 8,313,277 |
| 10/07/26 | CN¥23.96 | -0.58% | 6,180,996 |
| 09/07/26 | CN¥24.10 | +1.30% | 10,088,901 |
| 08/07/26 | CN¥23.79 | +3.03% | 6,130,162 |
| 07/07/26 | CN¥23.09 | -0.99% | 6,702,181 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600566 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition